NLRP3 and COVID-19: • SARS-Cov-2 infection leads to NLRP3 inflammasome activation, caspase-1 cleavage, and the release of IL-1β. This stimulates pyroptosis in peripheral blood mononuclear cells from severe COVID-19 (Rodrigues et al., 2020).